Terumo Corp (TRUMY)
17.08
+0.18
(+1.07%)
USD |
OTCM |
May 28, 15:59
Terumo Enterprise Value: 25.10B for May 24, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 24, 2024 | 25.10B |
| May 23, 2024 | 24.85B |
| May 22, 2024 | 24.88B |
| May 21, 2024 | 25.57B |
| May 20, 2024 | 26.49B |
| May 17, 2024 | 25.86B |
| May 16, 2024 | 26.36B |
| May 15, 2024 | 26.13B |
| May 14, 2024 | 25.47B |
| May 13, 2024 | 25.22B |
| May 10, 2024 | 25.02B |
| May 09, 2024 | 25.01B |
| May 08, 2024 | 24.61B |
| May 07, 2024 | 25.44B |
| May 06, 2024 | 26.02B |
| May 03, 2024 | 25.83B |
| May 02, 2024 | 25.38B |
| May 01, 2024 | 24.82B |
| April 30, 2024 | 25.13B |
| April 29, 2024 | 25.04B |
| April 26, 2024 | 24.65B |
| April 25, 2024 | 24.68B |
| April 24, 2024 | 25.38B |
| April 23, 2024 | 25.32B |
| April 22, 2024 | 25.16B |
| Date | Value |
|---|---|
| April 19, 2024 | 24.40B |
| April 18, 2024 | 24.51B |
| April 17, 2024 | 24.79B |
| April 16, 2024 | 25.23B |
| April 15, 2024 | 24.55B |
| April 12, 2024 | 24.89B |
| April 11, 2024 | 24.80B |
| April 10, 2024 | 24.99B |
| April 09, 2024 | 25.78B |
| April 08, 2024 | 26.19B |
| April 05, 2024 | 26.01B |
| April 04, 2024 | 26.09B |
| April 03, 2024 | 25.94B |
| April 02, 2024 | 26.62B |
| April 01, 2024 | 26.43B |
| March 31, 2024 | 27.31B |
| March 28, 2024 | 27.62B |
| March 27, 2024 | 28.05B |
| March 26, 2024 | 27.72B |
| March 25, 2024 | 27.40B |
| March 22, 2024 | 27.81B |
| March 21, 2024 | 28.34B |
| March 20, 2024 | 28.47B |
| March 19, 2024 | 28.26B |
| March 18, 2024 | 29.10B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
18.86B
Minimum
Oct 13 2023
38.76B
Maximum
Sep 27 2021
26.30B
Average
25.37B
Median
Enterprise Value Benchmarks
| Takeda Pharmaceutical Co Ltd | 70.05B |
| Nxera Pharma Co Ltd | 937.44M |
| PeptiDream Inc | 1.524B |
| Healios KK | 62.31M |
| AnGes Inc | 59.01M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 178.40M |
| Revenue (Quarterly) | 1.610B |
| Total Expenses (Quarterly) | 1.377B |
| EPS Diluted (Quarterly) | 0.1201 |
| Gross Profit Margin (Quarterly) | 52.04% |
| Profit Margin (Quarterly) | 11.08% |
| Earnings Yield | 2.89% |
| Operating Earnings Yield | 3.81% |
| Normalized Earnings Yield | 2.892 |